
Consider the four “P’s” of generic drugs that support the case for wider adoption of generics in the health system and beyond.
Download this checklist for an at-a-glance view of important considerations when modernizing your health system’s infusion service line.
By
Date
September 17, 2025
Read Time
2 minutes
Community-based infusion centers and payer-owned specialty pharmacies are increasingly stepping into the infusion space, fueled and perhaps even aided in part by policy and benefit design. For health systems already stretched thin, the solution isn’t to fight these changes with brute force or dig their heels in, nor is it to sit idly by – but to ask smarter questions about how, where, and why leakage is occurring.
“If hospitals want to minimize leakage – and, more importantly, keep patients connected to their care – they can’t afford to build their infusion strategy on assumptions.”
Answering these questions through a technology-forward, partnership-led approach – deliberately designed and proactively implemented – may be the foundation of a healthy infusion strategy that supports continuity of care and positions the health system for long-term success. By applying data analytics and predictive models, layered in with the guidance of industry experts like McKesson’s Specialty and Infusion for Health Systems teams, health systems may find answers to the most telling of questions, like where gaps exist and which therapies are driving the greatest financial or clinical risk.
To learn more about how partnering with McKesson can help your health system achieve more, download our exclusive checklist of questions to ask when evaluating your current infusion strategy, and contact us today.